Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;29(1):224-226.
doi: 10.3201/eid2901.220981. Epub 2022 Dec 18.

SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda

SARS-CoV-2 Omicron BA.5 Infections in Vaccinated Persons, Rural Uganda

Joseph Mugisha et al. Emerg Infect Dis. 2023 Jan.

Abstract

We describe a cluster of COVID-19 breakthrough infections after vaccination in Kyamulibwa, Kalungu District, Uganda. All but 1 infection were from SARS-CoV-2 Omicron strain BA.5.2.1. We identified 6 distinct genotypes by genome sequencing. Infections were mild, suggesting vaccination is not protective against infection but may limit disease severity.

Keywords: COVID-19; Omicron; SARS-CoV-2; Uganda; coronavirus disease; infections; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

PubMed Disclaimer

Figures

Figure
Figure
Nucleotide changes between SARS-CoV-2 genomes from a cluster of COVID-19–positive persons in Kyamulibwa, Kalungu District, rural Uganda. The lower portion of the chart shows nucleotide differences from the case 1 genome, plotted as white bars. The absence of bars in the BA.5.2.1 genomes from cases 1, 2, 7, and 10 indicates identical sequences. Case 5 was determined to be lineage BA.2.31, and cases 4, 6, 11, and 12 genomes demonstrated virus variants of lineage BA.5.2.1 distinct from the genomes from cases 1, 2, 7, and 10. A schematic of the SARS-CoV-2 genome is shown in the top portion of the chart, with protein coding regions marked.

References

    1. Tegally H, Moir M, Everatt J, Giovanetti M, Scheepers C, Wilkinson E, et al.; NGS-SA consortium. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med. 2022;28:1785–90. 10.1038/s41591-022-01911-2 - DOI - PMC - PubMed
    1. Kimura I, Yamasoba D, Tamura T, Nao N, Oda Y, Mitoma S, et al. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5. Cell, 2022;185(21):3992-4007.e16. ISSN 0092-8674 - PMC - PubMed
    1. Khan K, Karim F, Ganga Y, Bernstein M, Jule Z, Reedoy K, et al.; COMMIT-KZN Team. Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection. [Erratum in: Nat Commun. 2022 Oct 13;13] [1]. Nat Commun. 2022;13:4686. 10.1038/s41467-022-32396-9 - DOI - PMC - PubMed
    1. Wang Q, Guo Y, Iketani S, Nair MS, Li Z, Mohri H, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022;608:603–8. 10.1038/s41586-022-05053-w - DOI - PMC - PubMed
    1. Tuekprakhon A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, Ginn HM, Selvaraj M, et al.; OPTIC Consortium; ISARIC4C Consortium. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell. 2022;185:2422–2433.e13. 10.1016/j.cell.2022.06.005 - DOI - PMC - PubMed

Publication types

Supplementary concepts